Instead of requiring users to provision their own hardware or Virtual Private Servers (VPS), KiloClaw runs on a multi-tenant Virtual Machine (VM) architecture powered by Fly.io ...
This is the next in the series of investments from AbbVie to expand U.S. pharmaceutical manufacturing.
Outsource API manufacturing to India for lower costs, GMP-compliant quality, scalable production, and faster time-to-market for pharma companies.
AbbVie invests $380 million to build two new API manufacturing facilities in North Chicago while Bora Pharmaceuticals Co., Ltd. and GSK have renewed a five-year global manufacturing partnership.
Part of AbbVie’s vow to invest $100 billion in the U.S. over the next decade, the two Illinois facilities will make active ...
AbbVie has announced plans to invest $380m to construct two new active pharmaceutical ingredient (API) manufacturing ...
The Linux Foundation's CAMARA project is exposing telecommunications network capabilities to AI agents through the Model ...
AbbVie on Monday said it would invest $380 million to build two new active pharmaceutical ingredient manufacturing facilities ...
China has such a dominant position in active pharmaceutical ingredient (API) production that there is a risk it could "weaponise" access, according to a new congressional report. The document, from ...
MIDDLETOWN, DE, UNITED STATES, February 16, 2026 /EINPresswire.com/ -- Async, recently rebranded from Podcastle, today ...
The injectable medicine maker, whose U.S. headquarters are in Lake Zurich, said the collaboration with Phlow can be a model ensuring domestic production of a host of other essential medicines.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results